Thalidomide in the Treatment of Immune Reconstitution Inflammatory Syndrome in HIV Patients with Neurological Tuberculosis

AIDS Patient Care and STDs

Volumn 28, Issue 11, 2014, Pages 567-569

  Fourcade, Camille ^a   Mauboussin, Jean Marc ^a   Lechiche, Catherine ^a   Lavigne, Jean Philippe ^a   Sotto, Albert ^a  

^a NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; EMTRICITABINE; ETHAMBUTOL; GLUCOCORTICOID; ISONIAZID; METHYLPREDNISOLONE; MOXIFLOXACIN; PREDNISONE; PYRAZINAMIDE; PYRIDOXINE; RALTEGRAVIR; RIFAMPICIN; STREPTOMYCIN; TENOFOVIR; THALIDOMIDE; ANTIRETROVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT; TUBERCULOSTATIC AGENT;

ADD ON THERAPY; ADJUVANT THERAPY; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CASE REPORT; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; COMORBIDITY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; LETTER; MEDICATION COMPLIANCE; MIDDLE AGED; MONOTHERAPY; PARESTHESIA; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; TREATMENT RESPONSE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COMPLICATION; HIV INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MYCOBACTERIUM TUBERCULOSIS; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PSYCHOLOGY; TREATMENT OUTCOME; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NERVOUS SYSTEM DISEASES; NEUROLOGIC EXAMINATION; PARESIS; THALIDOMIDE; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84922281872     PISSN: 10872914     EISSN: 15577449     Source Type: Journal    
DOI: 10.1089/apc.2014.0083     Document Type: Letter

References (12)

1. Bourgarit A, Carcelain G, Martinez V, et al. Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006;20:F1-F7.
2. Müller M, Wandel S, Colebunders R, et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: A systematic review and meta-analysis. Lancet Infect Dis 2010;10:251-261.
3. Marais S,MeintjesG, PepperDJ, et al. Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome. Clin Infect Dis 2013;56:450-460.
4. Meintjes G, Wilkinson RJ, Morroni C, et al. Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS 2010;24:2381-2390.
5. Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: An open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013;13:27-35.
6. Brunel A-S, Reynes J, Tuaillon E, et al. Thalidomide for steroid-dependent immune reconstitution inflammatory syndromes during AIDS. AIDS 2012;26:2110-2112.
7. European Medical Agency. Thalidomide Celgene-(Previously Thalidomide Pharmion)-EMEA/H/C/000823-PSU/0031. 25/02/2009. http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product-Information/human/000823/WC500037050.pdf (Last accessed August 18, 2014).
8. Tadokera R, Meintjes G, Skolimowska KH, et al. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 2011;37: 1248-1259.
9. Franks ME, Macpherson GR, Figg WD. Thalidomide. Lancet 2004;363:1802-1811.
10. Van Toorn R, Rabie H, Dramowski A, Schoeman JF. Neurological manifestations of TB-IRIS: A report of 4 children. Eur J Paediatr Neurol 2012;16:676-682.
11. Roberts MTM, Mendelson M, Meyer P, Carmichael A, Lever AML. The use of thalidomide in the treatment of intracranial tuberculomas in adults: Two case reports. J Infect 2003;47:251-255.
12. WHO. Treatment of Tuberculosis Guidelines. Fourth Edition. http://whqlibdoc.who.int/publications/2010/9789241547833-eng.pdf?ua = 1 (Last accessed August 18, 2014).